Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H0LK
|
|||
| Drug Name |
IC9.GD2.CAR.IL-15 T-cells
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Neuroblastoma [ICD-11: 2D11.2] | Phase 1 | [1] | |
| Company |
UNC Lineberger Comprehensive Cancer Center
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Ganglioside GD2 (GD2) | Target Info | CAR-T-Cell-Therapy | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03721068) Phase I Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.